T cells limit accumulation of aggregate pathology following intrastriatal injection of α-synuclein fibrils
Sonia GeorgeiD, Trevor Tyson, Nolwen L. ReyiD, Rachael T. C. SheridaniD, Wouter PeelaertsiD, Katelyn BeckeriD, Emily Schulz, Lindsay K. MeyerdirkiD, Amanda Rae BurmeisteriD, Christian Ulrich von LinstowiD, Jennifer A. SteineriD, Martha L. Escobar GalvisiD, Jiyan MaiD, John Andrew PospisilikiD, Viviane LabrieiD, Lena BrundiniD, Patrik BrundiniD
Abstract
Background: -Synuclein (-syn) is the predominant protein in Lewy-body inclusions, which are pathological hallmarks of -synucleinopathies, such as Parkinsons disease (PD) and multiple system atrophy (MSA). Other hallmarks include activation of microglia, elevation of pro-inflammatory cytokines, as well as the activation of T and B cells. These immune changes point towards a dysregulation of both the innate and the adaptive immune system. T cells have been shown to recognize epitopes derived from -syn and altered populations of T cells have been found in PD and MSA patients, providing evidence that these cells can be key to the pathogenesis of the disease. Objective: To study the role of the adaptive immune system with respect to -syn pathology. Methods: We injected human -syn preformed fibrils (PFFs) into the striatum of immunocompromised mice (NSG) and assessed accumulation of phosphorylated -syn pathology, proteinase K-resistant -syn pathology and microgliosis in the striatum, substantia nigra and frontal cortex. We also assessed the impact of adoptive transfer of naive T and B cells into PFF-injected immunocompromised mice. Results: Compared to wildtype mice, NSG mice had an 8-fold increase in phosphorylated -syn pathology in the substantia nigra. Reconstituting the T cell population decreased the accumulation of phosphorylated -syn pathology and resulted in persistent microgliosis in the striatum when compared to non-transplanted mice. Conclusion: Our work provides evidence that T cells play a role in the pathogenesis of experimental -synucleinopathy.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 27
- FWCI
- 2.87
- Field percentile
- top 7%
- Organism
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Parkinson's disease-derived α-Synuclein assemblies combined with chronic-type inflammatory cues promote a neurotoxic microglial phenotype
Cansu Yildirim, Alexis Fenyi, … Stéphane Hunot·bioRxiv·Nov 30, 2023
- Alpha Synuclein Induced Immune Response Triggers Parkinson's Disease Like Symptoms
Rebekah G. Parkinson, Tony Xu, … Nathalie Dehorter·bioRxiv·May 27, 2024
- CD11b Activation Reduces Myeloid Brain Infiltration and Mitigates Synucleinopathy in a Model of Parkinson's Disease
Ameera M. Shaw, Viviana Jiménez, … Vineet Gupta·bioRxiv·Aug 11, 2025
- Lack of functional STING modulates immunity but does not protect dopaminergic neurons in the alpha-synuclein preformed fibrils Parkinson's Disease mouse model
Ida Hyllen Klæstrup, Line Sinnathamby Reinert, … Marina Romero‐Ramos·npj Parkinson s DiseasePeer-reviewed·Dec 11, 2025
- Engineered α-Synuclein-specific nanobody CAR iTregs restrain neuroinflammation and proteinopathy in Parkinson's disease mice
Alice Calderoni, Melania Nannoni, … Vania Broccoli·bioRxiv·Aug 22, 2026
- MHC class II transactivator effects on local and systemic immune responses in an α-synuclein seeded rat model for Parkinson's disease
Filip Fredlund, Itzia Jiménez-Ferrer, … Maria Swanberg·bioRxiv·Dec 2, 2022